Jessica St. Laurent, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iodide Peroxidase | 1 | 2021 | 293 | 0.690 |
Why?
|
| Endometrial Neoplasms | 4 | 2020 | 1353 | 0.660 |
Why?
|
| Hydatidiform Mole | 1 | 2021 | 279 | 0.650 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1213 | 0.560 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 2924 | 0.430 |
Why?
|
| Papillomaviridae | 1 | 2018 | 1119 | 0.410 |
Why?
|
| Papillomavirus Vaccines | 1 | 2018 | 491 | 0.410 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2020 | 271 | 0.300 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 1587 | 0.280 |
Why?
|
| Disease Progression | 1 | 2021 | 13284 | 0.240 |
Why?
|
| Virulence Factors | 2 | 2017 | 509 | 0.190 |
Why?
|
| Selenoproteins | 1 | 2021 | 216 | 0.170 |
Why?
|
| Hysterectomy | 2 | 2020 | 927 | 0.150 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2017 | 1219 | 0.150 |
Why?
|
| Corneal Ulcer | 1 | 2017 | 169 | 0.130 |
Why?
|
| Pseudomonas Infections | 2 | 2017 | 613 | 0.130 |
Why?
|
| Ovary | 1 | 2019 | 981 | 0.120 |
Why?
|
| Eye Infections, Bacterial | 1 | 2017 | 235 | 0.120 |
Why?
|
| Brachytherapy | 1 | 2020 | 1248 | 0.110 |
Why?
|
| Epoxy Compounds | 1 | 2012 | 136 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 471 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 2016 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 1061 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 3848 | 0.100 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 2645 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2014 | 721 | 0.090 |
Why?
|
| Neoplasms | 1 | 2018 | 21683 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 1122 | 0.070 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2020 | 709 | 0.070 |
Why?
|
| Breast | 1 | 2014 | 1969 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9239 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3690 | 0.050 |
Why?
|
| Stem Cells | 1 | 2014 | 3567 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 40561 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2020 | 77449 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 1465 | 0.040 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2020 | 6895 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 29144 | 0.040 |
Why?
|
| Female | 7 | 2021 | 380194 | 0.040 |
Why?
|
| Endometrium | 1 | 2020 | 424 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2017 | 212 | 0.040 |
Why?
|
| Humans | 9 | 2021 | 744343 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1770 | 0.030 |
Why?
|
| Japan | 1 | 2019 | 1360 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56430 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 1261 | 0.030 |
Why?
|
| Middle Aged | 4 | 2020 | 213383 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 163280 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 954 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 85781 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3616 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 107 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 501 | 0.030 |
Why?
|
| Operon | 1 | 2012 | 363 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1877 | 0.020 |
Why?
|
| Progesterone | 1 | 2014 | 776 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1266 | 0.020 |
Why?
|
| Estrogens | 1 | 2014 | 1566 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 3282 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 4320 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11031 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 2689 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11366 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3505 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 1177 | 0.010 |
Why?
|
| Binding Sites | 1 | 2012 | 6114 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12951 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5867 | 0.010 |
Why?
|
| Protein Binding | 1 | 2012 | 9386 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23338 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10481 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16689 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16365 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
| United States | 1 | 2019 | 69872 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 29786 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 2014 | 168757 | 0.000 |
Why?
|
| Male | 1 | 2017 | 350118 | 0.000 |
Why?
|